Evidence map›Paper›PMID 23875738›Full record

ArticleJournal of translational medicine2013

Vitamin D deficiency impacts on expression of toll-like receptor-2 and cytokine profile: a pilot study.

Samar Ojaimi, Narelle A Skinner, Boyd Jg Strauss, Vijaya Sundararajan, Ian Woolley, Kumar Visvanathan

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05376189 (The Effect of Vitamin D Supplementation on Toll-Like Receptor), which is not on this map. Cited by 38 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05376189 phase2 / phase3unknown statusnot on this mapstarted 2022, after this paper: background citation

The Effect of Vitamin D Supplementation on Toll-Like Receptor (TLR) 2, 4, and Clinical Outcomes of Spondylitis Tuberculosis

TypeinterventionalSponsorHasanuddin UniversityRan2022 to 2023Enrolled37ConditionsSpondylitis, TuberculosisArms400 IU, 5000 IU, 10000 IU, Fixed Drug Combination
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 2 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Vitamin D in the Prevention and Treatment of Inflammatory Skin Diseases.International journal of molecular sciences · 2025
    Review
  9. Article
  10. Review
  11. Long-term in vivo vitamin DScientific reports · 2023
    Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Samar OjaimiDepartment of Infectious Diseases, Southern Health, Clayton Rd, Clayton, Victoria, Australia.
Narelle A Skinner
Boyd Jg Strauss
Vijaya Sundararajan
Ian Woolley
Kumar Visvanathan
Monash University · AUSt Vincent's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVitamin D is believed to play an important role outside the endocrine system in the regulation of the immune system, and in cellular proliferation and differentiation. The aim of the study was to investigate the impact of vitamin D levels on innate immunity.

methodsParticipants for this prospective, longitudinal study were recruited amongst otherwise healthy staff of a large hospital in Victoria, Australia. Those fulfilling the inclusion criteria, including a vitamin D level of <50 nmol/L, were supplemented. Using flow cytometry, expression of the innate immune receptors TLR2, TLR4 and CD86 was measured on peripheral blood mononuclear cells (PBMCs) collected prior to vitamin D treatment and then at 1 and 3 months. Additonally, PBMCs at each timepoint were stimulated with specific TLR ligands and resultant supernatants were assayed for the cytokines TNFα, IL-6, IFN-α and IP-10.

resultsIn participants whose vitamin D level was >100 nmol/L post supplementation (n=11), TLR2 expression on PBMCs increased significantly, with no change noted in TLR4 or CD86 expression. Stimulation of vitamin D deficient samples with TLR ligands produced a number of proinflammatory cytokines, which were significantly reduced upon vitamin D normalisation. In patients whose levels returned to a deficient level at 3 months despite ongoing low-level supplementation, an increase in the pro-inflamamtory state returned. This suggests that vitamin D may play an important role in ensuring an appropriate baseline pro-inflammatory state.

conclusionsThis ex-vivo pilot study adds clinical evidence supporting a possibly important role for vitamin D in innate immunity. If confirmed, this unique clinical study has potentially significant implications for the treatment of a variety of inflammatory conditions, where achieving optimal vitamin D levels may help reduce inflammation.

Indexed as

Gene Expression RegulationAdultCell DifferentiationCell ProliferationChemokine CXCL10CytokinesDietary SupplementsEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryHumansImmunity, InnateInflammationInterferon-alphaInterleukin-6LigandsChemokine CXCL10CytokinesInterferon-alphaInterleukin-6LigandsTLR2 protein, humanToll-Like Receptor 2Tumor Necrosis Factor-alphaVitamin D

Identifiers

PMID23875738
PMCPMC3733619
OpenAlexW2111974687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.